Login
Manage Portfolio
Post a StockTalk
Write an Instablog
Get Daily Email Alert
Seeking Alpha
Home
The Macro View
Stocks & Sectors
Global Markets
ETFs
Investing Ideas
Breaking News
Transcripts
Business Intelligence
Immunomedics, Inc. (IMMU)
(
)
Quotes
Dashboard
Chart
Historical Prices
Options
Analysis
Articles
Instablogs
StockTalks
Sentiment
Comments
News & PR
Market Currents
Buzz
Twitter: IMMU
Coverage
Top Authors
Cramer
Top Analysts
Business Intelligence
Transcripts
Events
Key Developments
Earnings
History & Projected
Consensus
Peer Earnings
Filings
SEC Filings
Annual Report
Ownership
Major Holders
Insider Trades
Insider Sentiment
Index Membership
Short Interest
Financials
Income Statement
Balance Sheet
Cash Flow
Company
Wikipedia Profile
Officers & Directors
Executive Comp
52wk high:
52wk low:
EPS:
PE:
Dividend:
Yield:
Market Cap:
Exchange:
Analysis - Latest Articles
Trial Results Bode Well for Human Genome Sciences
EP Vantage
•
Nov 02
•
Comment!
Weekly Street Sentiment: Market Prepares for ‘Trick or Treat’
First Coverage
•
Oct 27
•
Comment!
Immunomedics Gets a Lot of Things Right
EP Vantage
•
Oct 03
•
Comment!
Spectrum Pharmaceuticals: Despite Share Offering, Still Cheap vs. Other Cancer Drugmakers
Justin M. Hall
•
Sep 20
•
3 Comments
Biotech Busy with Bevy of Small Deals
The Burrill Report
•
Sep 12
•
1 Comment
Spectrum Pharma: Post-Zevalin Approval Sales Should Ramp Up
Justin M. Hall
•
Sep 11
•
23 Comments
More articles on IMMU »
Instablogs
FIRST COVERAGE WEEKLY SENTIMENT (October 27, 2009): Market Prepares for ‘Trick or Treat.’
Mon October 26, 2009
•
First Coverage
•
Comment!
Spectrum Pharmaceuticals: $50 Million Vote of Confidence or Cause for Concern
Fri September 18, 2009
•
Justin M. Hall
•
15 Comments
Spectrum Pharmaceuticals: Post Zevalin Approval Sales Should Ramp Up
Fri September 11, 2009
•
Justin M. Hall
•
10 Comments
Write a post on IMMU
|
More Instablogs on IMMU »
Sentiment
What advice would you give to
IMMU?
123 characters left
What's your view of IMMU?
Make sure you include IMMU
140 characters left
|
Settings